Elevated plasma levels of Gal-3 were also associated with increased risks of rapid renal function decline, incident CKD and progressive renal impairment, as well as with CVD events, infection and all-cause mortality in patients with renal function impairment [86]. This evidence concerns the gene LGALS3 and chronic kidney disease.